PROGNOSTIC VALUE OF PRE-RADIOTHERAPY FDG-PET IN ADVANCED HODGKIN' S DISEASE TREATED BY BEACOPP CHEMOTHERAPY REGIMEN

被引：0
|
作者：
Chiesa, S. [1 ]
De Santis, M. C. [1 ]
Teofili, L. [2 ]
Manfrida, S. [1 ]
Vannata, B. [2 ]
Frascino, V. [1 ]
Fiorentino, A. [1 ]
Calcagni, L. [3 ]
Hohaus, S. [2 ]
Balducci, M. [1 ]
机构：
[1] Catholic Univ, Policlin Univ A Gemelli, Radiol Dept, Rome, Italy
[2] Catholic Univ, Policlin Univ A Gemelli, Haematol & Oncol Day Unit, Rome, Italy
[3] Catholic Univ, Policlin Univ A Gemelli, Nucl Med, Rome, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 94卷
关键词：
D O I：
10.1016/S0167-8140(15)34534-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
115
引用
收藏
页码：S44 / S45
页数：2
相关论文
共 50 条
  • [21] Prognostic value of 18F-FDG-PET/CT in Hodgkin disease patients during chemotherapy
    Colandrea, M.
    Travaini, L. L.
    Trifiro, G.
    Cocorocchio, E.
    De Cicco, C.
    Fracassi, S.
    Vanazzi, A.
    Calabrese, M.
    Martinelli, G.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S335 - S335
  • [22] RESPONSE ASSESSMENT AFTER 4 CYCLES OF BEACOPP USING FDG-PET IN PATIENTS WITH ADVANCED-STAGE HODGKIN LYMPHOMA
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Dedeckova, K.
    Mocikova, H.
    Klaskova, K.
    Kahraman, D.
    Dietlein, M.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2011, 22 : 160 - 160
  • [23] Prognostic value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy
    Enomoto, Keisuke
    Inohara, Hidenori
    Higuchi, Ichiro
    Hamada, Kenichiro
    Tomiyama, Yoichiro
    Kubo, Takeshi
    Hatazawa, Jun
    MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (04) : 224 - 229
  • [24] Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
    Keisuke Enomoto
    Hidenori Inohara
    Ichiro Higuchi
    Kenichiro Hamada
    Yoichiro Tomiyama
    Takeshi Kubo
    Jun Hatazawa
    Molecular Imaging and Biology, 2009, 11 : 291 - 291
  • [25] Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
    Keisuke Enomoto
    Hidenori Inohara
    Ichiro Higuchi
    Kenichiro Hamada
    Yoichiro Tomiyama
    Takeshi Kubo
    Jun Hatazawa
    Molecular Imaging and Biology, 2008, 10
  • [26] Early interim FDG-PET during intensified BEACOPP therapy for advancedstage Hodgkin disease shows a lower predictive value than during ABVD
    Gallamini, A.
    Viviaru, S.
    Bonfante, V.
    Levis, A.
    Di Raimondo, F.
    Merli, F.
    Vitolo, U.
    Bolis, S.
    Torchio, P. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 143 - 144
  • [27] Prognostic valve of FDG-PET after first line treatment in patients with Hodgkin's disease.
    Spaepen, K
    Stroobants, S
    Dupont, P
    Vandenberghe, P
    De Wolf-Peeters, C
    Thomas, J
    Verhoef, G
    Mortelmans, L
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 119P - 120P
  • [28] Prognostic value of the maximum standardized uptake value of staging FDG-PET/CT in Hodgkin lymphoma.
    Hu, Boyu
    Potluri, Alekhya
    Torigian, Drew A.
    Heltjan, Daniel F.
    Nasta, Sunita
    Schuster, Stephen J.
    Svoboda, Jakub
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] FDG-PET guided consolidative radiotherapy in patients with advanced stage Hodgkin lymphoma with residual abnormalities on post chemotherapy CT scan
    Savage, Kerry J.
    Connors, Joseph M.
    Wilson, Don
    Klasa, Richard
    Shenkier, Tamara
    Hoskins, Paul
    Voss, Nicholas
    Sehn, Laurie H.
    BLOOD, 2007, 110 (11) : 70A - 70A
  • [30] Role of radiotherapy in advanced Hodgkin's disease treated with the hybrid MOPP/ABVD (MAMA) regimen
    Levis, A
    Depaoli, L
    Ricardi, U
    Bertini, M
    Botto, B
    Ciravegna, G
    Gallo, E
    Gavarotti, P
    Cambrin, GR
    Rossi, M
    Salvi, F
    Resegotti, I
    BLOOD, 1995, 86 (10) : 196 - 196
12345